S L Walmsley
Overview
Explore the profile of S L Walmsley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhabokritsky A, Szadkowski L, Burchell A, Cooper C, Hogg R, Hull M, et al.
HIV Med
. 2021 Jun;
22(8):759-769.
PMID: 34075683
Objectives: The aim of this study was to assess the adequacy of immunological recovery and virological suppression in response to antiretroviral therapy (ART) in the growing population of older people...
2.
Sharma M, Walmsley S
HIV Med
. 2015 Feb;
16(6):329-36.
PMID: 25689044
Objectives: Women of reproductive age represent a large proportion of the global population living with HIV/AIDS. With improvements in morbidity and mortality since the advent of combination antiretroviral therapy, contraception...
3.
Lake J, McComsey G, Hulgan T, Wanke C, Mangili A, Walmsley S, et al.
HIV Med
. 2014 Feb;
15(7):431-41.
PMID: 24506429
Objectives: Soluble CD14 (sCD14) is a monocyte activation marker associated with increased mortality in HIV infection. We assessed 48-week changes in sCD14 and other inflammatory biomarkers in virologically suppressed, HIV-infected...
4.
Loutfy M, Harris M, Raboud J, Antoniou T, Kovacs C, Shen S, et al.
HIV Med
. 2007 Sep;
8(7):427-32.
PMID: 17760734
Objectives: To determine the severity of injection site reactions (ISRs), patient quality of life (QoL) and preference when enfuvirtide is administered by the Biojector (Bioject, Medical Technologies, Inc., Tualatin, OR,...
5.
Loutfy M, Raboud J, Montaner J, Antoniou T, Wynhoven B, Smaill F, et al.
Antiviral Res
. 2007 Jan;
75(1):58-63.
PMID: 17196268
In this study, we retrospectively assessed a gp41 genotypic assay in 404 enfuvirtide-naïve individuals (340 clade B, 64 non-B clade) to determine the prevalence of baseline polymorphisms and in 41...
6.
Walmsley S, Kelly D, Tseng A, Humar A, Harrigan P
AIDS
. 2001 Aug;
15(12):1581-4.
PMID: 11504994
In a retrospective cohort study of salvage antiretroviral combination therapy including efavirenz, 60% of 51 patients were able to suppress HIV RNA by at least 1 log10 or to less...
7.
Tsoukas C, Turner H, Hatzakis G, Blake G, Goodhew J, Kilby D, et al.
AIDS Res Hum Retroviruses
. 2001 Jul;
17(10):887-900.
PMID: 11461675
Five HIV-seropositive twins were treated with HAART and given cycles of treatment consisting of adoptive cellular therapy from their HIV-seronegative identical twins followed by a 5-day course of intravenous IL-2....
8.
Walmsley S, Becker M, Zhang M, Humar A, Harrigan P
Antivir Ther
. 2001 Jun;
6(1):47-54.
PMID: 11417761
Different salvage strategies have been used to regain control in patients with HIV who have virological failure on combination antiretroviral therapy. We conducted a cohort study of 63 extensively antiretroviral...
9.
Muller M, Richardson D, Walmsley S
Clin Nephrol
. 2001 Feb;
55(1):80-4.
PMID: 11200873
A 45-year-old man underwent renal transplant for end-stage renal disease complicating systemic lupus erythematosis. Within 24 hours of initiating Pneumocystis carinii pneumonia (PCP) prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) he developed fever...
10.